Clinical Research
Explore the latest developments in cellular research, including stem cell therapy, regenerative medicine, and innovative approaches to treating diseases at the cellular level.
Certain genetic alterations may contribute to primary resistance of certain cancers to KRAS G12C inhibitors
The KRAS G12C mutation is found in approximately 3% of all colorectal cancer cases and 1% to 2% of pancreatic adenocarcinoma cases, according to Hao Xie, MD, PhD, a medical oncologist at Mayo Clinic Comprehensive Cancer Center.
Common painkiller might help stop cancer from spreading
Most cancer deaths happen not because of the main tumor, but because cancer cells spread to other parts of the body. This process is called metastasis. When cancer spreads, it becomes much harder to treat.
DNA origami offers more accurate imaging in the fight against pancreatic cancer
One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue
Himalayan fungus compound tweaked for 40x anti-cancer boost
By using a compound derived from a Himalayan fungus and used for centuries in Chinese medicine as a jumping off point, scientists have developed a new chemotherapy drug with powerful anti-cancer effects. Doing so involved chemically altering the compound to better infiltrate cancerous cells, which proved to boost its potency by up to 40 times.
How vitamin B3 could help fight cancer
Scientists from the University of Minnesota have found a new way to boost the body’s natural defenses against cancer.
Immunotherapy Could Replace Surgery for Certain Types of Cancer, New Study Finds
Results from a groundbreaking clinical trial could soon change the way certain types of cancers are treated.
New genetic code may be the key in understanding origins of ovarian cancer, new treatment options
ICHMOND, Va. (WRIC) — A group of scientists at Virginia Commonwealth University (VCU) may have the key to discovering cancer’s origins within the body, as well as insights into new treatment strategies for ovarian cancer.
Radioiodine therapy found to improve relative survival rates of differentiated thyroid cancer patients
Differentiated thyroid cancer patients who receive radioiodine (RAI) treatment after surgery have increased relative survival rates compared to those who do not receive the treatment.
Root cause of pancreatic cancer and new treatment
Pancreatic cancer is one of the deadliest forms of cancer. A specific type called pancreatic ductal adenocarcinoma, or PDAC, is especially aggressive. Right now, there are no truly effective treatments for this kind of cancer. Sadly, only about 8 out of every 100 people diagnosed with PDAC live longer than five years.
Small-cell lung cancer (SCLC) is one of the most aggressive and deadly types of cancer, often linked to smoking.
f you’re following a high-protein or keto diet, fruit might not be at the top of your grocery list. But when it comes to weight loss as part of a balanced diet, fruit can actually be a helpful ally.
Walking This Many Steps Can Reduce Your Risk of 13 Types of Cancer
The benefits of walking are irrefutable. Of course, taking a daily stroll can help you lose weight, but it can also reduce depression risk, keep your brain sharp, and improve your cardiovascular health.
The Targeted Pulse: Discover the FDAÕs Holiday Moves For Solid Tumors, Gastric, and GEJ Cancers
The subcutaneous formulation of nivolumab (Opdivo Qvantig) received FDA approval for all previously approved adult solid tumor indications as monotherapy, maintenance therapy, or in combination with chemotherapy or cabozantinib (Cabometyx). Data from the phase 3 CheckMate-67T study (NCT04810078) provided support for this approval. In the trial, subcutaneous nivolumab was compared with its intravenous formulation.
